Magnetically‐activated lipid nanocarriers in biomedical applications: A review of current status and perspective
WIREs Nanomedicine and Nanobiotechnology · 2023-05 · 15 (3)
DOI: 10.1002/wnan.1863 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 25.11.2022. Verfasst von Xiaohan Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, Aust…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanostructures. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Novo Nordisk Fonden.
Abstract (Originalsprache)
Magnetically‐activated lipid nanocarriers have become a research hotspot in the field of biomedicine. Liposomes and other lipid‐based carriers possess good biocompatibility as well as the ability to carrying therapeutic cargo with a range of physicochemical properties. Previous studies have demonstrated that magnetic materials have potential wide applications in clinical diagnosis and therapy, such as in MRI as contrast agents and in hyperthermic obliteration of cancer tissues. More recently magneto‐thermal activation of lipid carriers to stimulate drug release has extended the range of further therapeutic benefits. Here, an overview of the current development of magnetically‐activated lipid nanocarriers in the field of biomedicine is provided, including the methods of fabrication of the nanocarriers and their in vitro and in vivo performance. A discussion of the current barriers to translation of these materials as medicines is provided in the context of clinical and regulatory complexities of using magnetically responsive materials in therapeutic applications. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology‐Inspired Nanomaterials > Lipid‐Based Structures Implantable Materials and Surgical Technologies > Nanomaterials and Implants
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, Australia.
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, Australia.
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ben J Boyd
Förderung
- Australian Research Council
- Novo Nordisk Fonden
Zitieren
APA
Sun, X., Tan, A., & Boyd, B. J. (2023). Magnetically‐activated lipid nanocarriers in biomedical applications: A review of current status and perspective. WIREs Nanomedicine and Nanobiotechnology, 15(3). https://doi.org/10.1002/wnan.1863
Vancouver
Sun X, Tan A, Boyd BJ. Magnetically‐activated lipid nanocarriers in biomedical applications: A review of current status and perspective. WIREs Nanomedicine and Nanobiotechnology. 2023;15(3). doi:10.1002/wnan.1863
BibTeX
@article{Sun2023,
author = {Sun, Xiaohan and Tan, Angel and Boyd, Ben J},
title = {Magnetically‐activated lipid nanocarriers in biomedical applications: A review of current status and perspective},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2023},
volume = {15},
number = {3},
doi = {10.1002/wnan.1863}
}
EUVIMED